Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Enhance MD vs WeightRx

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #17Desk pick
Enhance MD

The clearest tiered compounded pricing in the ranking — separate lines for sema, tirzepatide, a microdose tier, and a sema+tirz combo — with lab testing built in.

Marked down on: Compounded only — not FDA-approved

vs
Dispatch #201
WeightRx

WeightRx is a telehealth provider publishing compounded semaglutide at $250/mo and compounded tirzepatide at $83/mo.

Marked down on: The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term

Enhance MD takes this head-to-head with the higher Desk Score, 85/100 (B) against 66/100 (C) for WeightRx. WeightRx still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Enhance MD

85/100

B

Overall

WeightRx

66/100

C

Price transparency

82
86

State access

60
24

Molecule range

78
66

Onboarding speed

82
74

Support responsiveness

86
78

Licensing & trust

84
73

The spec sheet

FieldEnhance MDWeightRx
Semaglutide$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay$250/mo (compounded)
Tirzepatide$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay$83/mo (term not published, compounded)
CoverageNot publicly listedCoverage not published
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forPatients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes.Readers who want the lowest published tirzepatide figure, if you are willing to complete intake before you can read the plan terms.
Desk Score85/100B66/100C

The verdict

Desk pick — Enhance MD

Enhance MD takes this head-to-head with the higher Desk Score, 85/100 (B) against 66/100 (C) for WeightRx. WeightRx still holds its ground where its strengths line up with yours.

Choose Enhance MD if…

Patients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes.

$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay sema · $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay tirz · Not publicly listed

Choose WeightRx if…

Readers who want the lowest published tirzepatide figure, if you are willing to complete intake before you can read the plan terms.

$250/mo (compounded) sema · $83/mo (term not published, compounded) tirz · Coverage not published

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Enhance MD · WeightRx.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.